Abstract
In adults inhaling salbutamol via metered-dose inhalers (MDIs) 200 μ.g doses are recommended, but with diskhalers the manufacturer advocates 400 rather than 200 µg doses. To assess this advice, a partially double-blind, placebo-controlled salbutamol dose response, crossover study (also incorporating MDI doses) was conducted in 12 mild/moderate asthmatics. After active treatment, mean peak expiratory flow rate (PEFR) increments yielded no clinically or statistically significant differences; compared to placebo, respective median differences in PEFR increments (95% CIs) were 10 (-10, 50), 20 (0, 50), and 15 (0, 30) following 400 and 200 µg via diskhalers and 200 u.g via MDIs. Diskhalers are a suitable alternative for patients with poor MDI technique, but the use of 400 rather than 200 µg salbutamol doses is not supported by evidence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
